Volta AF-Xplorer

The Volta AF-Xplorer is a diagnostic computer designed to identify and map spatiotemporal dispersion in atrial electrograms for real-time guidance of ablation procedures in patients with atrial fibrillation and tachycardia. It integrates with existing EP systems to analyze patient electrograms and presents regions of interest graphically, with clinical data indicating its previous version, when combined with PVI, improved AF freedom at one year in drug-refractory persistent AF, despite increased atrial tachycardia and longer procedure times.

The Volta AF-Xplorer is a Class II programmable diagnostic computer designed to assist operators in the real-time manual or automatic annotation of 3D anatomical and electrical maps of human atria. Its core function is to identify multipolar intra-cardiac atrial electrograms displaying spatiotemporal dispersion during atrial fibrillation or atrial tachycardia. The system operates by integrating with existing catheters and specific electrophysiology recording and 3D mapping systems, analyzing patient electrograms to highlight regions of interest, and presenting these findings graphically for either manual or automatic tagging within the corresponding mapping system, thereby providing a technological solution for precise electrogram analysis. Clinical performance data from the Tailored-AF study informed an update to the device's indications for use. This study indicated that ablation guided by a previous version of the device, when combined with pulmonary vein isolation (PVI), was superior to PVI alone in achieving freedom from atrial fibrillation at one year in patients with drug-refractory persistent AF. However, this approach did not demonstrate greater success in achieving freedom from any atrial arrhythmia, largely due to an increase in atrial tachycardia occurrences. Additionally, the tailored ablation procedure was associated with a higher incidence of minor complications and significantly longer procedure and ablation times. Despite these outcomes, the device is considered safe and effective, with its updated indications deemed not to alter its fundamental purpose or introduce new safety or effectiveness concerns, affirming its substantial equivalence to a previously marketed version.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. Given the increased incidence of atrial tachycardia and longer procedure times, what specific patient selection criteria or procedural modifications could optimize outcomes and minimize adverse events with Volta AF-Xplorer guided ablation?; How does the Volta AF-Xplorer's algorithm specifically identify and characterize spatiotemporal dispersion in electrograms, and what are the clinical implications of these specific dispersion patterns?; What is the long-term efficacy and safety profile of Volta AF-Xplorer guided ablation beyond one year, particularly regarding the persistence of atrial tachycardia and the need for re-interventions?; Could the Volta AF-Xplorer be integrated with advanced imaging modalities to provide more comprehensive anatomical and electrophysiological insights before and during ablation procedures?; What is the learning curve for operators to effectively use the Volta AF-Xplorer for both manual and automatic annotation, and how does operator experience impact procedural outcomes?